Clovis Oncology: Outlook Post-Tesaro Acquisition [Seeking Alpha]
Clovis Oncology, Inc. (CLVS)
Last clovis oncology, inc. earnings: 2/24 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
phx.corporate-ir.net/phoenix.zhtml?c=247187&p=irol-irhome
Company Research
Source: Seeking Alpha
Shares of Clovis Oncology ( CLVS ) have lost nearly two-thirds of their value since my Reader Inquiry piece from April asked whether label expansion for Rubraca made the stock a buy (answer obvious in hindsight). However, the stock has risen by nearly 40% from recent lows after competitor Tesaro ( TSRO ) was acquired by GlaxoSmithKline for $75 per share or $5.1 billion in an all-cash deal. Interestingly enough, the acquisition price represented nearly a 150% gain from recent lows (great case study in market cycles of optimism in 2017 followed by extreme pessimism recently creating an opportunity for the risk-tolerant). As new life has been breathed into the PARP inhibitor niche, I figure it´s an ideal time to revisit Clovis and see what we can look forward to in 2019. Chart Figure 1: CLVS daily advanced chart (Source: Finviz) Figure 2: CLVS 15-minute chart (Source: Finviz) When looking at charts, clarity often comes from taking a look
Show less
Read more
Impact Snapshot
Event Time:
CLVS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CLVS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CLVS alerts
High impacting Clovis Oncology, Inc. news events
Weekly update
A roundup of the hottest topics